Skip to content ↓

Brain and Cog dedication Friday

The Brain and Cognitive Sciences Complex will be officially dedicated in a ceremony in the atrium on Friday, Dec. 2, at 3 p.m.

Chairman of the Corporation Dana G. Mead will offer a few words of welcome, followed by remarks from President Susan Hockfield and Cambridge Mayor Michael A. Sullivan.

Sullivan will be followed by Mriganka Sur, head of the Department of Brain and Cognitive Sciences; Robert Desimone, director of the McGovern Institute for Brain Research; Susumu Tonegawa, director of the Picower Institute for Learning and Memory; and Robert J. Silbey, dean of the School of Science.

A community reception will follow from 4-5 p.m.

In advance of the dedication, the Department of Brain and Cognitive Sciences will hold a symposium in celebration of the 40th anniversary of the department's graduate program -- "Looking Back, Looking Forward: Shaping Neuroscience and Cognitive Science" -- from 9:30 a.m. to 12:30 p.m. on Friday in the atrium.

The Picower Institute for Learning and Memory will hold its own inaugural events on Thursday, Dec. 1. The daylong symposium on "The Future of the Brain," which will be webcast live, will feature five Nobel laureates discussing brain research starting at 9 a.m.

A version of this article appeared in MIT Tech Talk on November 30, 2005 (download PDF).

Related Links

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story